The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use

Journal of the Medical Association of Thailand

Volumn 92, Issue 4, 2009, Pages 461-465

  Senthong, A Jaree ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Medroxyprogesterone 17 acetate; Tranexamic acid; Uterine hemorrhage

Indexed keywords

MEDROXYPROGESTERONE ACETATE; PLACEBO; TRANEXAMIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; NAUSEA; OUTCOME ASSESSMENT; SHORT COURSE THERAPY; SPOTTING; TREATMENT DURATION; TREATMENT RESPONSE; UTERUS BLEEDING; VOMITING;

ADULT; ANTIFIBRINOLYTIC AGENTS; CONTRACEPTIVE AGENTS, FEMALE; DOUBLE-BLIND METHOD; ENDOMETRIUM; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MENSTRUATION DISTURBANCES; MIDDLE AGED; PREGNANCY; TRANEXAMIC ACID; UTERINE HEMORRHAGE;

EID: 65649137360     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Taneepanichskul S, Reinprayoon D, Phaosavadi S. DMPA use above the age of 35 in Thai women. Contraception 2000; 61: 281-282 (Pubitemid 30427217)
2. Chotnopparatpattara P, Taneepanichskul S. Use of depot medroxyprogesterone acetate in Thai adolescents. Contraception 2000; 62: 137-140
3. Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, Kovacs G, et al. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum Reprod 2002; 17: 1189-1198
4. Lockwood CJ, Runic R, Wan L, Krikun G, Demopolous R, Schatz F. The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception. Hum Reprod 2000; 15 (Suppl 3): 144-151
5. Subakir SB, Abdul MO, Sabariah S, Affandi B. Oxidative stress, vitamin E and progestin breakthrough bleeding. Hum Reprod 2000; 15 (Suppl 3): 18-23.
6. Fraser IS, Hickey M. Endometrial vascular changes and bleeding disturbances with long-acting progestins. Steroids 2000; 65: 665-670
7. Mitchell MD. Reproductive roles of eicosamoids. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery and technology. Philadelphia: Lippincott-Raven; 1996: 841-858
8. Speroff L, Fritz MA. Long-acting of contraception. In: Speroff L, Fritz MA, editors. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005: 949-969 (Pubitemid 41653108)
9. Tantiwattanakul P, Taneepanichskul S. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users. Contraception 2004; 70: 277-279 (Pubitemid 39286761)
10. Nathirojanakun P, Taneepanichskul S, Sappakitkumjorn N. Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. Contraception 2006; 73: 584-587 (Pubitemid 43766213)
11. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003; 63: 1417-1433 (Pubitemid 36776096)
12. th ed. New York: McGraw Hill; 2004: 543-560
13. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996; 313: 579-582 (Pubitemid 26293640)
14. Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 1995; 102: 401-406
15. Runic R, Schatz F, Krey L, Demopoulos R, Thung S, Wan L, et al. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using norplant-2 contraception. J Clin Endocrinol Metab 1997; 82: 1983-1988.
16. Phupong V, Sophonsritsuk A, Taneepanichskul S. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use. Contraception 2006; 73: 253-256 (Pubitemid 43202175)